Derichebourg (PNU) Share Price

Goon 💩

FYI: "Docket last updated: 07/05/2024 11:59 PM EDT" -- It looks like your information on XERI's appeal is a few months out of date!

https://www.pacermonitor.com/public/case/51016327/Xeriant,_Inc_v_Auctus_Fund_LLC

One more week equals 20 trading days Nils. Are you going to come through or fail like the past 4 years with similar claims??

Unfortunately, not! Silicon Investor moderators are voted by the board that they already post within…

Thanks for posting that PR. There's obviously a LOT going on over at Treasury at the moment. A name change and reverse stock split to name just two.

I'm personally not a fan of doing reverse splits, but why they're doing this one may be more in relation to the Black Wolf merger would

Hi t 53!! But do you really still believe in the resurrection? I, on the other hand, these days am thinking of using wcvc as a tax loss. I haven't decided yet but I'm seriously thinking about it

Not playing the fool. The company records the SPS issued for free, I did not find where the company took a charge.

Wiseman Quote “The $1 billion decrease to additional-paid-in capital to record the initial senior preferred stock issued to Treasury is reflected as a reduction to core

$CDBT Chart = #UnderValued
https://www.barchart.com/stocks/quotes/CDBT/overview#google_vignette

🔴🔴AMC *is* 12.8x UNDERVALUED Ooops Ken GRIFFIN?!:

https://investorshub.advfn.com/uimage/uploads/2024/7/7/hyfhcAMC_I_DID_THATb.png
https://investorshub.advfn.com/uimage/uploads/2024/6/10/bblghAMC_128x_BTC_2.png
https://in

Heritage, Project 2025, so you admit trump wants to destroy American women, you used Heritage, Project 2025.

It's no big deal. They aren't sharing anything special. They just don't want to post all the ridiculous stories publicly as they get shown how ridiculous they are.
Remember, they've been playing this game, the three of them for over 4.5 years now.

So now you're saying that SecuritiesLawyer101.com was just making up the entire appeal by the Basile Law Firm? Did it ever occur to you than XERI simply added Basile as co-counsel?

EXCELLENT ARTICLE!!!

“…“The approved amyloid drugs, like Leqembi [lecanemab], are not approved for prevention, but only for treatment in the mildest cases of Alzheimer’s disease. That is good to do, but still too late.” He added that lecanemab “is too costly, at over $60,000 per year,

https://www.kraiglabs.com/kraig-biocraft-laboratories-targets-vertical-markets-for-its-spider-silk-and-shares-planned-applications/

“During the ramp-up phase, while production quantities are relatively limited, the Company is targeting end-product applications in fashion and performan

All means nothing at this point. My challenge stands. Get back to me when they get financial judgements that are in-line with the "billions and billions of ongoing" infringements that the CEO has spoken about. If not then it's a complete failure and confirmation that the patents aren't worth near as

Kinda like the deal that was done with Amazon last fall? LMAO!!

Why the hell would anyone in their right mind want to visit this den of iniquity?
As a result, more than 16,500 hotel rooms across New York City are being occupied by migrants, driving up room prices and making the city more expensive than ever for tourists and visitors . Last year, the aver

Once again, you think you know more than the actual experts. A classic example of the old saying: "A little knowledge is a dangerous thing."

LWLG is not only on the map. They wrote the map!

$80mm company merging with a trip zero stinky pinky?

Riiiight!

I have some ocean front property in Colorado for sale… interested?

This is NOTHING but BS LIES since there has been no update on the Auctus case. It still shows that William Igbokwe was the LAST lawyer to enter a motion in the appeal CASE. We can clearly see in court records for the XERI/XTI case the courts recorded the CHANGES of Attorneys.

How coul

https://www.zerohedge.com/medical/should-alzheimers-be-treated-it-becomes-symptomatic-experts-weigh

Sorry it was Morgan Stanley not Merrill Lynch.